Manipal Journal of Pharmaceutical Sciences
Volume 3

Issue 2

Article 5

1-9-2017

Pursuing pharmacovigilance career in the industry
Anand Harugeri
Safety Aggregate Reporting and Analytics, Marketed Product Safety Services, Lifecycle Safety, Quintiles
Research (India) Private Limited, QuintilesIMS, Bengaluru, India, anandbh@yahoo.com

Denzil Machado
Business Development US and Canada, Data Sciences, Safety and Regulatory, QuintilesIMS, Raleigh, USA

Vineet Shastri
Business Development US and Canada, Data Sciences, Safety and Regulatory, QuintilesIMS, Raleigh, USA

Follow this and additional works at: https://impressions.manipal.edu/mjps

Recommended Citation
Harugeri, Anand; Machado, Denzil; and Shastri, Vineet (2017) "Pursuing pharmacovigilance career in the
industry," Manipal Journal of Pharmaceutical Sciences: Vol. 3 : Iss. 2 , Article 5.
Available at: https://impressions.manipal.edu/mjps/vol3/iss2/5

This Review Article is brought to you for free and open access by the MAHE Journals at Impressions@MAHE. It has
been accepted for inclusion in Manipal Journal of Pharmaceutical Sciences by an authorized editor of
Impressions@MAHE. For more information, please contact impressions@manipal.edu.

Harugeri et al.: Pursuing pharmacovigilance career in the industry
Harugeri A, Machado D, Shastri V, et al: Pursuing pharmacovigilance career in the industry

Review Article

Pursuing pharmacovigilance career in the industry
Anand Harugeri*, Denzil Machado, Vineet Shastri
Email: anandbh@yahoo.com

Abstract
Pharmacovigilance (PV) offers plenty of opportunities for career development in pharmaceutical industry. With
increased number of drugs and biologics entering the market and enhanced drugs safety regulatory framework,
need for skilled resources to carry out PV activities has gained importance. Increased drug safety awareness
has also demanded robust yet cost-effective PV systems and operations. As a result of this, PV outsourcing
has gained momentum, thus, increasing job opportunities. The PV market has recently seen an exponential
growth. PV as a science is now well-established in the biopharmaceutical industry as well. A typical PV operation
will have various functional units such as Individual Case Safety Report (ICSR) Processing, Medical Review,
Literature Search and Review, Aggregate Report Preparation, Signal Detection, Pharmaco-epidemiology and
Risk Management, Labelling, and Qualified Person for PV (QPPV or QP). Multiple other interface functions
support and empower PV functional units or vice versa. Any aspiring PV professional is required to possess both
technical and soft skills. Academically, the candidate should hold a degree in life science, nursing, pharmacy or
medicine. A previous industry experience is of great value. Additionally, candidates should also possess essential
soft skills. A career in PV is equally or more fulfilling than any other allied healthcare career because the work
focused on patient safety involves collecting and analyzing safety data for a large number of medicinal products.
This article aims to enlighten job aspirants regarding various aspects related to choosing and pursuing a career
in PV.
Key words: Pharmacovigilance, drug industry, career choice, drug-related side effects and adverse reactions,
pharmaceutical services

Introduction
The World Health Organization (WHO) defines PV
as the science and activities relating to the detection,
assessment, understanding and prevention of
adverse effects or any other drug-related problem.1
In simple terms, PV involves a number of activities
aimed at identifying risks associated with medicinal
products and ensures that their harmful effects on
patients are prevented or minimized. The reason
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for adopting PV by the pharmaceutical companies
is because the majority of healthcare regulatory
bodies around the globe such as Drugs Controller
General of India (DCGI), United States Food and
Drug Administration (US-FDA), The European
Medicines Agency (EMA) have laid out regulations
and directives on PV for pharmaceutical companies.
Every pharmaceutical company developing or
marketing a medicinal product is expected to comply
with these PV regulations to ensure patient safety.
Failing to comply with the regulations may have
consequences including cancellation of the drug
development program or marketing authorization
and criminal proceedings against the company.
Noncompliance will also damage the reputation and
trust of the company.
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The importance of PV has gained attention over
the years and stakeholder base is widening with
many new pharmaceutical products added to
the market each year. Historically, many drugs
have been withdrawn from the market owing to
their safety in the patient population because of
which regulations around continuous benefit-risk
monitoring of drugs are now tighter than ever. The
growing biopharmaceutical industry offers plenty
of opportunities for career development. These
opportunities are spread across various segments
of the industry such as manufacturing, research
and development, information technology and bioinformatics, medical and regulatory affairs, clinical
trial operations, sales and marketing, consulting,
finance, quality control and assurance, PV, and few
others. Of these, PV has gained importance over the
past decade across the globe and continues to do so.

The unique nature of PV service involving both
healthcare and informatics has provided plenty of
career options for a large pool of talents, both fresh
and experienced. The need for talented resources
to proactively manage patient safety is increasing
and there is a shortage of talent pool in PV market.
A career in PV, hence, can be both rewarding and
enriching in terms of exposure and experience. With
more players entering into this job market coupled
with increased need for a more strategically placed
efficient systems and methodologies have made the
job market more dynamic and demanding. This
article aims to enlighten job aspirants regarding
various aspects related to choosing PV as a career.
Core Pharmacovigilance Functions in the
Industry and their Responsibilities
The PV is a specialty in the industry as along with the
soft skills, it requires specific knowledge and skills
related to pharmacology, pharmacotherapeutics,

Table 1: Pharmacovigilance functions and their responsibilities
Functional Unit

Key Responsibilities
Collection and triage of ADR in safety database.
Perform duplicate check, data entry, QC
Data coding (AE and Drug coding), causality assessment, follow-up
Data reconciliation and expedited reporting

ICSR Processing

•
•
•
•

Literature Search and
Review

• Identification of biomedical literature and lay press for safety surveillance
• Literature review to identify AE and ADR for ICSR processing, signal detection, and aggregate
report preparation

Medical Review

• Medical review of ICSRs, periodic reports, and adhoc reports
• Medical review of signals and RMPs/REMS

Aggregate Report
Preparation

• Preparation of PBRER, DSUR, and other periodic safety reports
• Generation and review of line listings
• Prepare adhoc reports as requested by HA

Signal Detection,
Pharmaco-epidemiology,
and Risk Management

• Screening of various data sources such as Clinical Trial and spontaneous reporting systems,
literature, external databases, and others to identify signals through data mining
• Signal validation, prioritization, and evaluation
• Preparation of RMPs/REMS, communication with HA, follow-up on action items
• Benefit-risk assessment in PBRERs, RMPs, and other reports
• Safety communication

Labelling

• Creation and maintenance of the labels for company’s products
• Review of safety information document like CCDS and CCSI, country level labels, pack inserts,
and patient information leaflets
• Monitoring of safety labelling of products of other companies and implementation of health
authority requests for safety-related labelling changes

QPPV or QP

• Oversight of company PV systems and processes
• Overview of safety profile of the products and communicate with HA as required
• Point of contact for HA with respect to company PV activities

Long forms: ADR-Adverse Drug Reactions, AE-Adverse Events, DSUR-Development Safety Update Report, CCDS-Company Core
Data Sheet, CCSI-Company Core Safety Information, HA-Health Authorities, ICSR-Individual Case Safety Report, PBRER-Periodic
Benefit Risk Evaluation Report, PV-Pharmacovigilance, QC-Quality Control, QPPV or PV-Qualified Person for Pharmacovigilance,
REMS-Risk Evaluation and Mitigations Strategies, RMP-Risk management Plan.
14
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pharmaco-epidemiology, PV methodologies, PV
information sources, critical evaluation of biomedical
literature, regulations, systems, and processes. Core
PV functions in a pharmaceutical industry are listed
in Table 1. The PV remains a specialized department
within the research and development (R and D)
operations of a pharmaceutical company and can
be functioning within clinical research, regulatory
affairs or medical affairs units or as a separate entity.
When such an activity is outsourced to a third party,
such as to a Contract Research Organization (CRO)
or Business Processing Organization (BPO), the
PV operations are considered as a separate arm of
service delivery within the third party.
The operations typically begin with case handling
process where the clinical trial adverse event (AE)
and spontaneous adverse drug reaction (ADR)
reports are received from various sources such
as investigation sites, health care professionals,
patients, general public, literature publications, and
regulatory authorities. Many companies have set-up
dedicated call centres called as medical information
centres for the purpose of providing information
regarding their pharmaceutical products. These
centres also collect spontaneous ADR reports. The
received AE or ADR reports are further processed
through data entry, data coding, medical review,
and quality control workflows using a dedicated
safety system cum database. Some of these reports,
commonly called as Individual Case Safety Report
(ICSR) may qualify for expedited reporting to
regulatory authority if they qualify the expedited
reporting criteria stipulated in the guidelines.2,3As
well, the data captured in the safety database are
utilized for the purpose of signal detection, benefitrisk management, and periodic safety report writing.
They are typically managed by separate functions
outside the case handling function in the majority
of the companies.
The PV operations also involve functions such as
those involved in creating and developing Risk
Management Plans (RMPs) and Risk Evaluation
and Mitigation Strategy (REMS). The objective of
RMP and REMS documents is to ensure the safety of
the patients by providing detailed guidance on risks
associated with the use of the medicines, monitoring,

and interventions to minimize such risks. The only
difference among these two documents is that REMS
is required by the US-FDA, whereas RMP is specific
to EMA.
An extended arm of PV operations could also
involve teams supporting the drug label updates.
The drug labels include EU summary of product
characteristics (SPC), United States Package
Insert (USPI), etc. Certain countries follow region
or country specific label formats. The content of
such labels is derived based on a company position
document called Company Core Data Sheet (CCDS)
and PV groups are responsible for providing upto-date content with respect to safety data into
the CCDS. The PV specialist and PV physicians
routinely review drug labels and CCDS to ensure
that most updated information related to product’s
safety data is included in them.
Interface functions with pharmacovigilance
Beyond core functions, the PV department is
empowered and supported by management,
regulatory affairs, clinical research, legal department,
medical affairs, medical information, literature search
and review, information technology and information
services, training team, quality control/assurance,
project management, manufacturing operations,
supply chain, product security, sales and marketing,
and external partners liaison team (Figure 1).
Medical Information (MI) call centres typically
handles queries related to medicinal products
from various sources like patients and healthcare
professionals. These centres manage inquiry receipt
and processing of the requests. The MI staff may
also receive ADR reports that are further processed
into a safety database by the ICSR processing
teams. Therefore, it is important that a proper
workflow is established between MI and PV teams
to process the received ADR in a timely fashion.
Medical affairs group in a pharmaceutical company
is comprised of licensed physicians responsible for
various medico-marketing activities. Medical affairs
team also reviews ICSRs, periodic safety reports as
well as other safety documents from medical and
clinical practice perspective. PV function works with
medical affairs for various post authorization efficacy
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Figure 1: Pharmacovigilance Interface Functions

and safety studies, non-interventional studies and
investigator-initiated studies. A close collaboration
between medical affairs and PV is key because a
medical review of the safety data is paramount before
submission to health authorities. This ensures that
an appropriate company comment is provided to the
ICSRs as well as reviewing periodic safety reports.
The PV function is obligated to train all staff
in the pharmaceutical company including sales
and marketing staff to receive and report ADR
reports to ensure 100% coverage of incoming
safety reports. Healthcare professionals usually
raise safety concerns associated with medications
like ADR and product quality complaints to the
sales and marketing teams as they are the primary
contact points from pharmaceutical companies. The
regulatory affairs team works very closely with the
PV group since the former is the liaison between
regulatory authorities and pharmaceutical company,
and responsible for submission of the expedited
and periodic safety reports to various regulatory
agencies. The regulatory group works very closely
with the PV during label revisions and renewal of
product license in various countries. An effective
collaborative strategy between these two groups
16

ensures that the regulatory obligations are met
consistently.
Another interface function that works closely with
the PV function is the compliance and training
group. This group plays an important part in a PV
set-up since it ensures that the company is compliant
with all legislations and guidelines in terms of its PV
obligations and also in terms of providing required
training and exposure to human resources working
in various PV functions. The compliance teams
support PV for quality management and assurance
including audits and inspections. The staff working
in compliance and training group are required to
be aware of the PV domain expertise. Therefore,
this group usually will have staff with required PV
experience.
The role of Information Technology (IT) is
inevitable in PV like any other function within the
pharmaceutical industry to develop, deploy and
maintain the PV systems like clinical and safety
databases, drug and ADR dictionaries, tracking
tools, and repositories. It certainly plays a significant
role in ensuring all systems and tools utilized for
PV delivery are established in cost-effective yet
compliant manner. Guidelines such as 21 CFR Part

Manipal Journal of Pharmaceutical Sciences | September 2017 | Volume 3 | Issue 2

https://impressions.manipal.edu/mjps/vol3/iss2/5

4

Harugeri et al.: Pursuing pharmacovigilance career in the industry
Harugeri A, Machado D, Shastri V, et al: Pursuing pharmacovigilance career in the industry

11 of the US FDA require that all computerized
systems are compliant with established regulatory
framework and IT teams play an important role in
ensuring this.4 Over the last few years, there has
been a lot of investment in PV to bring in efficiency
through automation. The need for cross-functional
collaboration between IT and PV is increasing.
The legal team can have occasional engagement with
the PV team for various reasons. Their involvement
during processing of case reports arising from
litigation and lawsuits is very predominant.
Pharmaceutical companies often co-develop and
co-market products with other companies. In the
event of mergers and acquisitions, obligations
associated with medicinal product licenses are
transferred between companies. In all these types
of collaborative work between pharmaceutical
companies, the safety data exchange is dynamic and
driven by safety data exchange agreements (SDEA).
PV function works in close collaboration with the
legal team to establish and maintain SDEA.
Pharmacovigilance as specialty in the
pharmaceutical industry
The PV as a discipline is now well established in
the biopharmaceutical industry. The majority of
biopharmaceutical companies have either wellmanaged in-house PV department or partially/
completely outsource such activities to a third
party such as CRO or BPO. Achieving the required
quality outcome during the conduct of PV activities
by an organization is intrinsically related to the
availability of a sufficient number of competent
and appropriately qualified and trained personnel.
The majority of workflow and capacity planning is
dependent on qualified and trained human resources
due to the fact that the safety data requires thorough
assessment in the context of clinical practice and
pharmacotherapy. This helps to draw a meaningful
conclusion out and then submit this data in a predefined format for the purpose of regulatory
reporting. Also, regulatory guidelines, including the
International Council for Harmonization of Technical
Requirements for Pharmaceuticals for Human Use
(ICH) guidelines require that the personnel involved
in clinical research and PV activities are qualified by
education training, and experience to perform his or

her respective task(s).5,6 Because many of the clinical
research and PV operations are regularly subjected
to audits and inspections, it is expected that the PV
activities are conducted with integrity, high quality
and compliance to meet the regulatory standards.
Growth of pharmacovigilance business
The PV market has seen an exponential growth in
terms of volume and revenue over the last 6-7 years.
The growth is accompanied by increased outsourcing
of PV operations to CROs and BPOs, which are now
representing half of the overall market share in
drug safety.7 A recent industry report forecasts that
the PV market will exceed USD 8 billion by 2024
with Asia Pacific alone anticipated exceeding USD
2.4 billion by the same year.8 Major players in the
market are innovator and generic pharmaceutical
companies, CROs, BPOs, and Knowledge Processing
Organizations (KPOs). India, being the hub for many
of these companies, the PV market is expected to
reach USD 668 million by 2024. Increasing number
of clinical studies following recent regulatory
reforms along with the low operating cost of the
region can be attributed to this growth in India.9
Skills for a successful career in pharmacovigilance
A successful career in PV requires a combination of
both technical as well as soft skills. Organizations
have put in place established hiring plans for various
roles within PV and such plans require that the
candidates meet these minimum requirements. The
requirements increase with higher roles and such
requirements are explicitly described by the company
human resources (HR). Broadly, the requirements
can be classified into three categories:
1) Technical skills
Aspiring PV professionals are required to
be familiar with the basics of medicinal
products, health care, ADR and EU and Good
Pharmacovigilance Practices (GVP). Globally
there is a lack of specialized university certified
academic courses in this area. There are few
academic institutes that offer postgraduate
courses in PV such as MSc in PV.10,11,12 Few
institutes offer training in PV through certain
certificate or post-graduate diploma level
programs that could be helpful for aspirants.10,13,14
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The curriculum proposed by International
Society of Pharmacovigilance (ISoP) and
Uppsala Monitoring Centre (UMC) would
guide the aspirants to develop required technical
knowledge and skills to pursue PV career.15
Although there is a preference for healthcare
professionals in the pharmaceutical industry in
general, candidates with a life sciences degree can
get an entry-level job in PV. Hence, life science
graduates with basic knowledge of PV with basic
computer skills such MS Office can apply for a
PV role. The current PV organizations employ
staff with various academic backgrounds such
as allopathic medicine, dentistry, nursing, Indian
systems of medicine, pharmacy, and life sciences.
The PV organizations recruit mainly graduates
with a healthcare degree such as medicine
or pharmacy due to the advantage that their
academic curriculum which involves various
courses related to PV like human anatomy
and physiology, pharmacology, medicinal
chemistry,
pharmaceutics,
jurisprudence,
pharmacotherapeutics, good practices (Good
Clinical Practice (GCP), Good Manufacturing
Practice (GMP), and other GXPs). Regulatory
authority in India require PV activities to be
managed by medical or pharmacy graduates
with relevant training and experience.16 There
are few organizations, predominantly CROs and
BPOs who hire fresh talents from colleges as
trainees and impart on the job training in PV and
later be absorbed by the same organization based
on their performance during the probationary
period.
2) Soft skills
In addition to the required technical skills,
certain soft skills play an important role in
employability for a career in PV. A successful
candidate attending an interview for any PV
role has to exhibit competencies around the
soft skills that can supplement the technical
knowledge. These soft skills include, oral and
written communication, attention to detail,
organizational skills, presentation skills, faith
and confidence, flexibility, up skilling ability,
learning ability, and stability.
18

3) Skills to acquire for effective career
enhancement
Companies invest a lot of time and resource
in training their staff in soft skills. Very often
these are inadequate for a person’s overall career
development. Self-development is an aspect that
every professional is required to consider for a
fruitful career in addition to existing training
resources within an organization. The soft skills
play an important part in successful business
delivery, especially, when working in a CRO
or BPO where multiple clients are involved.
Efficient business delivery also depends on
the innovation and management of the PV
operations at all levels. In order to achieve this,
it is imperative that the PV operations are led
by strong leadership teams to ensure smooth
delivery and keep the cost under control.
Apart from the aforementioned technical and
soft skills, a successful career progression
also depends on the continuous learning and
development on the job. These skills help
professionals to learn beyond the existing
learning modules and continuously look for new
ideas and technologies to be successful. These
skills can be easily acquired and learned through
self-motivation and practice (Figure 2).
Typical career ladder for prospective PV
professionals
The career ladder for PV professionals varies
between companies and regions and based on the
scope of PV operations and organizational needs.
However, in the majority of organizations, the
career path starts with an Individual Contributor
(IC) role and further progresses into management
and leadership roles. The entry level job role may
include that of a Drug Safety (DS) Coordinator or
PV Coordinator role followed by DS/PV Associate
and Senior PV/DS Associate role. A job title of PV/
DS Scientist is also very common in the industry.
As the career progresses, the employee may assume
the role of a Project Lead/Team Lead and Project
Manager/Team Manager. However, the actual job
title would vary depending on the organizational
HR policies. Each of the job roles may have its own
ranking or level as assigned by the company HR
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Figure 2: Soft skills required for a successful career in pharmacovigilance

policies and these may be either alphabetically or
numerically ordered based on hierarchy.
•

•

Individual contributor roles: The entry
level job opportunity in the majority of the
organizations would be that of an IC. The
IC’s role within an organization is to provide
services based on the technical expertise that
the individual has gained through education and
training. These employees are either dedicated
to a project if working in a pharmaceutical
company or may work for multiple customers if
working for a service provider such as CRO or
BPO. They will deliver the core work in drug
safety and gradually make into higher IC roles
such as project lead or project manager (Figure
3). The employees will work only for the
assigned technical tasks and would not usually
take up any administrative, supervision or people
management roles. At this role, the person will
gain a lot of subject matter expertise with time
and will be able to become a domain expert.
Management roles: The management roles
within a PV set-up either involve project
management or people management or both.
Basically, these roles will involve providing
support and direction to the employees based
on the organization’s strategy and goals. The
job description may involve, but not limited to,

compensation and benefits, hiring, performance
management,
organization
and
people
development, employee engagement, employee
motivation, communication, administration,
resources and operations management, budget
and finance, and training. The managers are also
expected to provide strategic thoughts to the
growth of the organization through business
growth and increased profitability. This is
very crucial in the outsourcing business where
cost-effectiveness and compliance are critical
for success. Therefore, it is imperative that the
managers are aware of both people management
skills along with domain knowledge.
The PV organizations may either look at internal
talents with required education and experience for
managerial positions (internal vertical movement) or
hire externally. Companies may consider the internal
vertical movement to ensure that the candidate with
an in-depth understanding of the organizational
culture as well as basic understanding of the
business delivery model would lead the functions.
This is the reason that many companies invest a
lot of resource and time in nurturing the internal
talents and provide them training and exposure to
become future leaders of their company. Such an
approach will also ensure ranking equilibrium in
the organization and increase the retention of key
talents. Where required, companies would also reach
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Figure 3: Typical Career Ladder in PV (Individual Contributor)

out to external market to hire management talents
to suit the need especially for senior management
and executive roles. Cross-functional hiring has also
gained interest through lateral movement.
A typical entry level management position may
include that of an Assistant Manager progressing
into Associate Manager and Senior Manager. This
is followed by few leadership roles such as Associate
Director, Director and Senior Director. These roles
may further progress into executive roles such
as Vice President and Executive Vice President
(Figure 4). Several roles are evolving towards
the future of PV. These roles are influenced by
technological enhancements, business development,
and regulatory changes. Some of these roles include
business process analyst, benefit-risk management
specialist, project or program manager, PV systems
experts, and PV vendor management specialist.
Summary
The industry offers a wide variety of opportunities
in PV for graduates and postgraduates in medicine,
pharmacy, and life sciences in today’s world. A
career in PV is equally or more fulfilling than any
other allied healthcare career because the work
involves collecting and analyzing safety data for
a large number of medicinal products aimed at
patient safety. The candidates who pursue PV career
20

should be passionate because the outcome of their
work would have a social impact by minimizing
or mitigating the medication-related harm and
ensuring that patients receive medications which
outweigh the benefits compared to risks. The jobs in
the industry would require both technical and soft
skills for a successful career development. There are
plenty of career development opportunities once
a person gets into the PV job through continued
learning and development. The opportunities are
spread across pharmaceutical companies as well as
service providers such as CROs and BPOs.
The PV career opportunities continue to grow
proportional to the growth of biopharmaceutical
industry. Although the outsourcing of core PV
services like ICSR processing has gained momentum
over the last few years, the pharmaceutical
companies are also looking at internal resource
optimization and consolidation thereby keeping
the opportunity open for PV growth. Outsourcing
of niche and high-end work like signal detection
and risk management has also seen a rapid growth.
With increasing biopharmaceutical products in the
market, continuously changing regulations around
drug safety, rapidly fostering GVPs, and increased
outsourcing of PV services, it is expected that there
will be continuing demand for skilled PV human
resources in the job market. Career development
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Figure 4: Typical Career Ladder in PV (Management Role)

in PV industry is driven by continuous selfdevelopment. The PV professionals should explore
lateral and vertical growth, enrichment, realignment
and transition opportunities for a successful career
in the industry.

5
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